Vol. 282, Issue 3, R639-R648, March 2002
INVITED REVIEW
The multifaceted phenotype of the knockout mouse for the
KCNE1 potassium channel gene
Richard
Warth1 and
Jacques
Barhanin2
1 Physiologisches Institut, 8057 Zürich, Switzerland;
and 2 Institut de Pharmacologie du Centre National de la
Recherche Scientifique, 06560 Valbonne Sophia-Antipolis, France
 |
ABSTRACT |
Mutations
of the KCNE1 gene (IsK, minK) are related to hereditary forms of
cardiac arrhythmias, so-called long QT syndromes (LQT). Here we review
the phenotype of a mouse model for the recessive form of LQT known as
Jervell and Lange-Nielsen syndrome. KCNE1 knockout mice exhibit an
enhanced QT-RR adaptability, which is probably part of the
pathophysiological mechanism leading to life-threatening tachyarrhythmia in patients. Like patients, knockout mice are deaf and
show vestibular symptoms due to an impaired endolymph production.
Knockout mice show urinary and fecal salt wasting and volume depletion.
The renal phenotype is due to diminished reabsorption of
Na+ and glucose. The mice are hypokalemic and have
increased aldosterone levels. Besides volume depletion, aldosterone is
elevated via a set-point shift for sensing of extracellular
K+ in aldosterone-secreting glomerulosa cells, which
physiologically express KCNE1. In conclusion, KCNE1 knockout leads to a
complex phenotype resulting from direct loss of KCNE1 and compensatory mechanisms. Murine KCNE1 physiology could be helpful for the
pathophysiological understanding and perhaps gene-specific treatment of
long QT patients.
KvLQT1; long QT syndrome; kidney; heart
 |
INTRODUCTION |
POTASSIUM CHANNELS are found in
virtually all mammalian cells. They form the most diverse group of ion
channels (~80 pore-forming subunit genes) that can be divided into
three main structural classes comprising two, four, or six
transmembrane segments. All these K+ channel subunits have
in common a conserved motif called the P domain, which is part of the
K+-selective filter that provides the specificity to
K+ transport. In addition to the pore-forming subunits
themselves, K+ channels comprise in their structure
associated modulatory subunits designated as
-subunits. They
are usually not essential for the formation of the ionic pore, but they
determine the stability of the channel complex in the membrane
and modulate biophysical, regulatory, and
pharmacological properties (18).
KCNE1, also named IsK or minK, belongs to a family of small
transmembrane proteins (KCNE1, -2, -3, and -4 and KCNE1L). Originally KCNE1 was cloned from a rat kidney library and expressed in
Xenopus laevis oocytes, leading to a slowly activating
K+ current (IKs)
(70). However, KCNE1 has been regarded as somewhat of an
enigma in the ion channel field because it has none of the hallmarks of
conventional K+ channels, particularly the P domain.
Moreover, it was found that the amplitude of KCNE1 currents in oocytes
saturates at low levels of cRNA injections (9), and
attempts to express KCNE1 currents in numerous eukaryotic cells failed
(42). These observations indicated the lack of an
essential cofactor in these cells. The explanation of this
phenomenon is the coassembly of KCNE1 with a Shaker-type
K+ channel
-subunit, KCNQ1 (also named KvLQT1),
identified by positional cloning in patients with long QT syndrome
(6, 17, 61). KCNQ1 exists as an endogenous X. laevis KCNQ1 in oocytes (61). The assembly with KCNE1
increases the voltage dependence and current amplitude of KCNQ1, slows
down activation kinetics, and changes pharmacological properties (Fig.
1, A and B)
(10). Mutations in both genes are associated with a
hereditary form of cardiac arrhythmia, so-called long QT syndromes
(7, 38, 55). Monoallelic mutations in either gene
cause the dominant form of the syndrome, called Romano-Ward syndrome
(RWS; long QT syndrome type 5), a life-threatening disease
characterized by prolonged cardiac repolarization and polymorph
ventricular arrhythmias. Biallelic mutations lead to the Jervell and
Lange-Nielsen syndrome (JLNS), with a severe long QT phenotype
associated with profound bilateral deafness (51, 73). In
the case of the RWS, mutations in other ion channel genes have also
been described (for review, see Refs. 38,
57). These genes include the Na+ channel gene
SCN5A and two K+ channel genes, KCNH2
(HERG) and KCNE2 (MiRP1),
the latter encoding a protein similar to KCNE1. In addition, two other
gene loci have been described that correspond to a ryanodine receptor
(RYR2) on chromosome 1q42 (56) and a yet unknown gene on
4q25 (62).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 1.
KCNE1 coassembles with KCNQ1. A: putative
membrane topology of KCNQ1 and KCNE1. KCNQ1 consists of 6 transmembrane
domains and 1 P loop between S5 and S6. KCNE1 has only 1 transmembrane
domain with the NH2 terminus facing the extracellular side.
B: effect of KCNE1 on KCNQ1 current. COS cells transfected
with KCNQ1 alone (Q1, top trace) or cotransfected with KCNQ1
and KCNE1 (Q1 + E1, bottom trace) were examined in
whole cell mode (clamp protocol: 80, +50, 40 mV). Q1 transfection
led to voltage-activated K+ outward current. Cotransfection
with Q1 and E1 enhanced current amplitude and voltage dependence and
slowed down activation kinetics. B is a kind gift from
Georges Romey, Sophia Antipolis, France (published with
permission).
|
|
Besides its assembly with KCNQ1, KCNE1 was also shown to associate with
KCNH2 (48) and Cl
channels (4).
However, these two types of interactions are less documented than the
one with KCNQ1 and still await confirmation. On the other hand, it is
clear that in addition to KCNE1, both KCNE2 (71) and KCNE3
(63) can interact with KCNQ1 to form K+
channels with specific biophysical properties (for review, see Ref.
60).
The KCNE1/KCNQ1 channel complex is abundant in heart muscle, inner ear,
and a variety of epithelial tissues (Fig.
2) (8, 65). The generation
of a null mutant mouse for the KCNE1 allows the detailed in vivo
exploration of the physiological roles of this specific channel in
cardiac as well as noncardiac tissues. In humans the KCNE1 gene is
located on chromosome 21q22.1-q22.2 (15) and in mice on
chromosome 16 (64.4 cM) (Ref. 37). For construction of the
knockout mouse the complete coding sequence (located on exon 2) was
deleted and replaced by the neomycin resistance gene (75).
In another KCNE1 knockout mouse model, in addition to deletion of the
KCNE1 coding sequence, lacZ and neomycin resistance genes were inserted
(40). Moreover, a spontaneous mutation leading to a
truncated protein (66 instead of 129 amino acids) has been reported
(43).

View larger version (73K):
[in this window]
[in a new window]
|
Fig. 2.
Distribution of KCNQ1 and its -subunits KCNE1, -2, and
-3 in mouse tissues. Besides in the heart, KCNQ1 is predominantly
expressed in epithelial tissues. KCNE1 was highly abundant in heart and
kidney. The strong expression in mouse stomach is in contrast to human
tissue, in which we could not detect KCNE1 (31). KCNE2 is
strongly expressed in stomach and eye, and KCNE3 is strongly expressed
in the intestinal tract. In contrast to recent studies (1,
2), we failed to detect KCNE2 and KCNE3 (63) in
heart and skeletal (sk) muscle, respectively. The primers were as
follows: KCNQ1 sense 5'-CTGAGAAAGATGCGGTGAAC-3', antisense
5'-TGGGGGTCAGCAGTGTCTCC-3'; KCNE1 sense
5'-CGACTGTTCTGCCCTTTCTG-3', antisense
5'-CTCAGTGGTGCCCCTACAAT-3'; KCNE2 sense 5'-GAGGAGGAACACAACAGC-3',
antisense 5'-CCAGGTTCTCATGGATGG-3'; KCNE3 sense
5'-AGCTCTTCCCATACCTCAAT-3', antisense 5'-AATCCTCTTACCAGTTTCCT-3';
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) sense
5'-GTGCTGGGCTACCTGCTCTA-3', antisense 5' TCGTCCTTGTCTTTCTTCAC
3'. The PCR was made under standard conditions using 32 cycles.
Specific KCNQ1 and KCNE1, -2, and -3 PCR products were recognized by
Southern hybridization with internal oligonucleotides. E16-18,
embryonic days 16-18.
|
|
The clinical relevance of KCNE1 mutations in humans is known for heart
and inner ear. Here we give an overview on the multitissue phenotype of
the KCNE1 knockout mouse, which could have an impact for human
pathophysiology and disease.
 |
KCNE1 KNOCKOUT MICE DISPLAY A MILD CARDIAC
PHENOTYPE |
Physiologically, repolarization of heart action potential is
dependent on several K+ conductances, including
KCNE1/KCNQ1. The cardiac KCNE1/KCNQ1 current
(IKs) is activated via depolarization during the
action potential and shows slow activation kinetics. In mouse heart, KCNE1 is strongly expressed with some decay during the first weeks after birth (25, 27). With PCR methods, we find KCNE1
abundant in both atrium and ventricle (Fig. 2).
-Galactosidase
activity, which was under control of the KCNE1 promoter, indicates a
strong and specific expression of KCNE1 in cells of the sinus node and atrioventricular node, in lower right atrial septum, and in the proximal conducting system. In the ventricle, cells belonging to the
conducting system are also stained (40).
Does KCNE1 gene disruption affect the heart action potential? In
one study microelectrode measurements show no difference in action
potential duration between knockout and wild-type mice (13). In electrocardiogram recordings, there is no direct
correlate of the QT prolongation observed in JLNS patients: QT interval is very similar in both genotypes under control condition and in the
presence of isoproterenol stimulation (25, 40). However, the QT-RR adaptation is significantly exacerbated in KCNE1 knockout mice, leading to a prolonged QT interval during bradycardia
(25). A similar increased QT-RR adaptability is described
for long QT patients (33, 50). What, then, is the
explanation for the shorter QT intervals in knockout mice at high heart
rates? One might speculate that KCNQ1 alone, which is still
present in KCNE1 knockout mice, could lead to a fast-activating
repolarizing K+ current at high heart rates. Furthermore,
secondary compensatory effects, i.e., via differences in plasma
K+ or high aldosterone, are possible explanations.
Taken together, the KCNE1 knockout mouse is an interesting model for
JLNS, but with clear limitations due to species differences. Concerning
the localization of KCNE1 in pacemaker cells and the conducting system,
especially in the lower right atrium, it is speculated that KCNE1 might
play a role in common reentrant arrhythmias such as atrioventricular
nodal reentrant tachycardia and common atrial flutter
(40). Further studies are needed to elucidate the
underlying mechanisms and a possible role of KCNE1 in more detail.
 |
KCNE1 GENE KNOCKOUT IS ASSOCIATED WITH DEAFNESS AND SHAKER-WALTZER
BEHAVIOR |
Endolymph is an extracellular fluid with a unique composition, a
high K+ concentration (150 mmol/l) and a low
Na+ concentration (4 mmol/l). The ionic composition is
crucial for signal transduction of sensory hair cells of the cochlear
duct and the vestibular labyrinth. Numerous genes are known to cause deafness (http://www.uia.ac.be/dnalab/hhh/). Among these, some genes
for membrane transporters and ion channels have been identified that
are involved in the complex mechanisms (69, 76) of
endolymph secretion and generation of the endocochlear potential:
Na+-2Cl
-K+ cotransporter
(21, 24, 28), H+ ATPase (36), and
KCNE1/KCNQ1 K+ channels. KCNE1 and KCNQ1 are localized in
the luminal membrane of endolymph-producing marginal cells from the
stria vascularis and of vestibular dark cells (11, 41, 52, 52,
59, 75) representing the efflux pathway for K+.
Their regulation by purinergic (47), adrenergic
(78), and muscarinic (77) receptors and cAMP
(67, 68) and their pharmacology (64) have
been described in detail.
Already in the 19th century cases of sudden death combined with
deafness were reported (49) probably corresponding to
JLNS. Like patients suffering from JLNS, KCNE1 knockout mice are also profoundly and bilaterally deaf and exhibit an obvious vestibular dysfunction, leading to rapid head bobbing and bidirectional circling, which is referred to as Shaker-Waltzer behavior (23, 40, 43, 75).
In the cochlea of the inner ear the position of Reissner's membrane is
dependent on the balance between endolymph production and reabsorption.
In KCNE1 knockout mice, Reissner's membrane collapses postnatally,
indicating that K+ secretion and concomitant water flux are
strongly reduced. This impaired endolymph production leads to cell
death of sensory hair cells and, within 6 wk, to degeneration of the
majority of the spiral ganglion neurons (75).
Interestingly, the cell layers of stria vascularis show slight
morphological changes, namely an enlargement of the intercellular space
in the intermediate cell layer, which corresponds to fluid waiting to
be secreted. The endolymph-producing marginal cells appear to be
grossly normal (75). In the vestibular labyrinth the
vestibular wall collapses, similar to Reissner's membrane in the
cochlea. Within 6-7 mo after birth, the sensory hair cells of the
vestibular system degenerate and disappear. Endolymph-producing
vestibular dark cells of KCNE1 knockout mice are larger but do not
undergo cell death (52). In Ussing chamber experiments
short-circuit current as a measure of secretion is almost completely
abolished in KCNE1 knockout mice (75). Interestingly,
KCNQ1 immunostaining of the luminal membrane of dark cells disappears
in KCNE1
/
mice, indicating that KCNE1 is essential for KCNQ1
membrane targeting and/or stability of KCNQ1 in the membrane (Fig.
3) (52). It is not presently known if KCNE1 also plays such a trafficking role in other
organs where it is associated with KCNQ1. More recently, it was shown that KCNQ1 knockout mice present similar inner ear pathology (11, 41).

View larger version (115K):
[in this window]
[in a new window]
|
Fig. 3.
Immunolocalization of KCNE1 and KCNQ1 in the vestibular system.
A: KCNE1 staining of a KCNE1 wild-type vestibular crista.
The endolymphatic space is located at top right. At the base
of each side of the crista, the luminal membrane of dark cells is
strongly stained (arrows). Other parts of the crista, sensory and
transitional epithelium, are not labeled. B: KCNQ1 staining
of a KCNE1 wild-type vestibular crista. As with KCNE1 protein, a strong
luminal staining of KCNQ1 (arrows) was detected. C: KCNQ1
staining of a KCNE1 knockout vestibular crista. Compared with wild type
in B, the KCNQ1-specific staining is lost. Please note the
changes in morphology and the collapse of the endolymphatic space (*).
Figure 3 is a kind gift from Marie-Thérèse Nicolas and
Danielle Demêmes, Monpeiller, France (published with permission).
|
|
In conclusion, the heteromultimeric KCNE1/KCNQ1 channel plays a key
role for physiological endolymph secretion, which is a prerequisite for
signal transduction in cochlea and vestibular system. In addition,
KCNE1 is essential for normal KCNQ1 localization and function in the
inner ear.
 |
ROLE OF KCNE1 FOR RENAL SALT AND WATER REABSORPTION |
In mammalian kidney, KCNE1 is predominantly expressed in proximal
tubules. Immunofluorescence experiments reveal a colocalization of
KCNE1 and KCNQ1 proteins in the brush-border membrane (22, 66,
74). However, a weaker expression of KCNE1 and KCNQ1 in other
nephron segments is not excluded by these experiments.
Is renal function affected by KCNE1 gene knockout? Interestingly, KCNE1
/
mice are hypokalemic and exhibit as a sign of dehydration an
increased hematocrit, suggesting an impaired renal electrolyte balance
and enhanced water loss (Fig. 4)
(3, 74). The inulin clearance as a measure of glomerular
filtration rate is not changed; however, the fractional excretion of
NaCl and fluid is markedly increased. Micropuncture experiments reveal a reduced K+ concentration in late proximal and early
distal tubular fluid of knockout mice due to a reduced proximal tubular
K+ efflux through luminal KCNE1 K+ channels
(74).

View larger version (63K):
[in this window]
[in a new window]
|
Fig. 4.
Localization and function of KCNE1 in the kidney.
A-D: immunolocalization of KCNE1 and KCNQ1.
A: KCNE1 staining (green) was most prominent in brush-border
membrane of proximal tubules. Hoe-33342 nucleus staining is shown in
blue, and differential interference contrast picture is in gray scale.
B: no KCNE1-specific staining was observed in KCNE1 knockout
( / ) mice. KCNQ1 (red) was almost absent in S1 segments of proximal
tubules (*; C) but colocalized with the KCNE1 in the
brush-border membrane of S2 and S3 segments (D).
Interestingly, KCNQ1 brush-border localization was not affected in
KCNE1 knockout mice. Inulin clearance experiments revealed an increased
fractional urinary Na+ excretion (FeNa+;
E) and a tendency to lose K+ (F). The
loss of salt and water led to an enhanced hematocrit (G) as
a means for volume depletion. Fecal and urinary K+ loss
induced a relative hypokalemia (H). Data were taken from
inulin clearance experiments under control conditions
(74). In the same study, the relative hypokalemia was not
observed after long-lasting micropuncture experiments; however, another
study using a larger number of animals without pretreatment [KCNE1
knockout 3.77 ± 0.12, KCNE1 wild-type mice 4.48 ± 0.08 mmol/l (3)] confirmed the reduced plasma K+
of KCNE1 knockout mice. FeK+, fractional urinary
K+ excretion. P < 0.05 vs. KCNE1
wild-type (+/+) mice.
|
|
Proximal tubules physiologically reabsorb Na+ and
substrates using Na+/H+ exchange (NHE3) and
Na+-coupled glucose and amino acid transport systems. This
Na+-coupled transport depolarizes the luminal membrane,
thereby reducing the driving force for further transport. Thus luminal
K+ channels are required to repolarize the luminal
membrane. In studies on isolated in vitro perfused proximal tubules of
KCNE1
/
mice, phenylalanine and glucose in the luminal fluid led to an enhanced depolarization of the membrane voltage compared with wild-type mice. The gene knockout could be mimicked by addition of the
K+ channel inhibitor Ba2+ to the luminal fluid
in perfused proximal tubules of wild-type mice (74). This
loss of driving force for substrate reabsorption explains the increased
fractional glucose excretion of KCNE1
/
mice. To exclude additional
effects of the knockout on distal nephron segments, amiloride can be
used as a pharmacological tool to assess Na+ reabsorption
via epithelial Na+ channels (ENaC). Interestingly,
amiloride gives rise to a higher Na+ excretion in knockout
mice, which argues against an impaired reabsorption of distal nephron segments.
Taken together, these data indicate an important role of the
KCNE1/KCNQ1 complex as a luminal K+ channel in mouse
proximal tubules. This K+ conductance located in the
brush-border membrane grants the driving force for electrogenic
Na+ and substrate reabsorption.
 |
ALDOSTERONE SECRETION IS REGULATED BY KCNE1-DEPENDENT
K+ CONDUCTANCE |
Under normal diet, KCNE1
/
mice exhibit
hemoconcentration and hypokalemia. Probably, the
hypokalemia is mostly due to an increased plasma aldosterone
concentration (Fig. 5). Interestingly, plasma renin concentrations under normal diet are similar in both wild-type and knockout mice, indicating that the increase in
aldosterone is not due to enhanced renin concentration. In KCNE1
knockout mice high aldosterone stimulates Na+ reabsorption
in distal colon, paralleled by enhanced K+ secretion and
fecal K+ loss. Also, renal fractional K+
excretion is enhanced but does not reach significance.
Low-Na+ diet increases and low-K+ diet reduces
aldosterone plasma concentrations in both genotypes in a similar way.
In contrast, under high-K+ diet, aldosterone is
approximately fivefold higher in KCNE1
/
mice, although plasma
K+ concentration is still lower than in wild-type mice
(3). The explanation for this surprising finding is the
expression of KCNE1 in aldosterone-producing adrenal glomerulosa cells.
Physiologically, aldosterone secretion is activated via two major
stimuli: high plasma K+ concentration and ANG II, both
finally leading to the activation of depolarization-activated T-type
Ca2+ channels. This Ca2+ influx then in turn
activates aldosterone secretion. The K+ conductance in
glomerulosa cells comprises at least two types of K+
channels. ANG II inhibits one type, namely TASK1 (19), via Ca2+/calmodulin-dependent protein kinase II and shifts the
voltage dependence of the T-type Ca2+ channel to more
hyperpolarized values (14). On the other hand, even small
increases in plasma K+ suffice to depolarize the cell,
thereby activating Ca2+ influx. This depolarization is
thought to activate voltage-dependent K+ channels, which
then limit the Ca2+ influx and aldosterone secretion
(45). The impressive effect of high-K+ diet in
KCNE1
/
mice, together with the increased aldosterone under
normal K+ diet without a concomitant increase in renin,
indicates a crucial role of KCNE1 for repolarization of glomerulosa
cells. A portion of the increase in aldosterone under
high-K+ diet is caused via renin. The elevated renin is
probably not due to a direct effect of the KCNE1 gene deletion on
renin-producing cells because they do not express KCNE1. The mechanism
by which renin is increased remains to be elucidated. Taken together,
these data suggest a concerted mechanism of action of the increased renin/ANG II concentration and enhanced K+ sensitivity of
glomerulosa cells in KCNE1
/
mice.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of KCNE1 gene disruption on aldosterone secretion.
KCNE1 knockout mice had an increased plasma aldosterone concentration
under normal diet (containing 0.9% K+) compared with
wild-type animals. Interestingly, plasma renin concentration was
similar for both genotypes under these conditions. At
high-K+ diet (3%), aldosterone was 5-fold increased in
knockout mice compared with wild-type mice, paralleled by a 3-fold
increase in renin. Under low-K+ diet (0.05%) and
low-Na+ diet (0.01%), aldosterone and renin concentrations
were not different among the genotypes (data from Ref.
3).
|
|
Further studies are required to investigate the impact of these data on
human pathology. Both low plasma K+ and high aldosterone
concentrations are possibly harmful: the occurrence of life-threatening
torsades de pointes arrhythmias in patients suffering from long QT
syndromes is especially high during hypokalemia (26, 58).
On the other hand, aldosterone was shown to have a deleterious effect
on the progression of chronic heart failure (54).
 |
KCNE1 IN EXOCRINE PANCREAS |
KCNE1 and KCNQ1 are abundant in pancreatic acinar cells (22,
70, 80), leading to a voltage-dependent and slowly
activating K+ current (39). In wild-type mice,
KCNQ1 seems to be mainly located in the basolateral membrane. However,
it cannot be excluded that KCNQ1 is present to a weaker extent in
luminal and vesicular membranes. Interestingly, in KCNE1
/
mice,
KCNQ1-specific immunofluorescence is less focused on the basolateral
membrane and also present in the cytosol, suggesting an impaired
membrane targeting of KCNQ1 (79). In addition, the
pancreatic secretory granules are irregularly distributed in KCNE1
/
mice: some acini are completely packed with granules, whereas
other acini are almost without any secretory granules. Unfortunately,
the pathophysiological mechanisms underlying this phenomenon are not understood.
The biophysical properties of the KCNE1/KCNQ1 K+ current in
pancreatic acini resemble very much the cardiac KCNE1/KCNQ1 channel complex (6, 61) and the voltage-dependent current observed in adrenal glomerulosa cells (6, 45). This component of
whole cell K+ current is strongly augmented in the washout
phase after cholinergic stimulation when the intracellular
Ca2+ activity and the Ca2+-activated
Cl
conductance are already decreased. In pancreatic
acinar cells of KCNE1
/
mice, this current is almost completely
abolished, indicating, together with the histological findings, a
functional role of KCNE1 in the KCNQ1 channel complex in rodent
pancreas (79). Further studies are needed to elucidate the
localization and physiological role of KCNE1 during electrolyte and
enzyme secretion.
 |
INTESTINAL ION TRANSPORT IS ALTERED IN KCNE1 / MICE |
In metabolic cage experiments KCNE1
/
mice lose an impressive
amount of Na+ and K+ with feces compared with
wild-type mice (3). The loss of K+ might be
explained by an increased secretion in distal colon due to stimulated
aldosterone secretion in knockout mice. In fact, we observe in KCNE1
/
mice threefold increased amiloride-sensitive Na+
reabsorption in Ussing chamber experiments of distal colon.
Intriguingly, this observation cannot explain the increased
Na+ loss via feces in metabolic cages, but one would expect
the opposite, namely a reduced loss of Na+. One might
speculate that similar to Na+ reabsorption in renal
proximal tubules, KCNE1 plays a role in Na+ and substrate
reabsorption in proximal parts of small intestine. However, we are not
able to detect a specific immunofluorescence, possibly due to an amount
of KCNE1 protein below our detection limit (79). In
contrast to immunofluorescence, Northern blot analysis reveals an
expression of KCNE1 in rat duodenum (70). Such a role of
KCNE1 in duodenal Na+-coupled transport together with the
aldosterone-stimulated K+ secretion in distal colon could
explain the combined fecal loss of Na+ and K+
in knockout mice. Theoretically, an enhanced Na+ content of
pancreatic/intestinal secretion could also cause the increased fecal
Na+ loss. Thus far, however, there is no experimental
evidence supporting this hypothesis.
 |
KCNE1 IN AIRWAY EPITHELIUM |
There is controversy in discussions of expression and function of
KCNE1 in airway epithelium. In two studies a basolateral K+
conductance (35) activated during regulatory volume
decrease (44) is reported to be KCNE1 dependent. In
contrast, we find no expression of KCNE1, but do find KCNE3, in murine
trachea. In KCNE1 knockout mice, electrogenic cAMP-mediated
Cl
secretion, which requires basolateral K+
channels to provide the driving force, is higher in KCNE1 knockout mice
(22, 32). Na+ reabsorption via epithelial
Na+ channels is slightly higher in KCNE1 knockout mice. One
possible explanation for these differences might be the altered hormone status after KCNE1 gene disruption, i.e., the enhanced aldosterone concentration (3). We conclude from these data that, at
least in mouse trachea, Cl
secretion and Na+
reabsorption do not require KCNE1.
 |
GASTRIC ACID SECRETION REQUIRES KCNQ1 BUT NOT KCNE1 |
KCNQ1 mRNA is abundant in gastric mucosa (16, 80),
suggesting a possible role of KCNQ1 for gastric ion transport.
Interestingly, KCNQ1 colocalizes with the gastric
H+-K+-ATPase in the tubulovesicular system of
the luminal membrane compartment (20, 31). Inhibition of
KCNQ1 by the chromanol 293B almost completely abolishes acid secretion
(31), and the KCNQ1 gene disruption leads to a loss of
acid secretion and gastric hyperplasia in knockout mice
(41). These results indicate a crucial role of KCNQ1 for
luminal K+ recycling during acid secretion. In rodent
stomach KCNE1, -2, and -3 (all putative KCNQ1
-subunits known so
far) are expressed, with the highest levels of expression for KCNE2
(20, 22, 31, 70). Localization of KCNE2 in parietal cells
by in situ hybridization (20) and activation of
KCNQ1/KCNE2 channels by acidic extracellular pH (31),
cAMP, and inositol 1,4,5-trisphosphate/Ca2+
(unpublished data) make KCNE2 the likely
-subunit of KCNQ1 in parietal cells. We exclude a major role of KCNE1 for H+
secretion in rodents because the KCNE1 gene disruption neither reduces
acid secretion nor changes the effect of the KCNQ1 inhibitor 293B
(31). In human stomach KCNE1 is not expressed, supporting the hypothesis that KCNE2 and/or KCNE3 coassemble with KCNQ1 to form
the luminal K+ conductance of parietal cells.
 |
KCNE1 KNOCKOUT MICE ACCUMULATE MATURE T LYMPHOCYTES |
In mouse thymus both KCNE1 and KCNQ1 are weakly expressed. They
are not detected in this tissue by PCR techniques using 32 cycles (Fig.
2) but are detected with 40 cycles (12).
Interestingly, KCNE1 gene disruption leads to accumulation of mature T
cells in thymus and peripheral lymphoid tissue of adult mice. However, the molecular mechanisms underlying this accumulation and the possible
functional modulation of the immune system by KCNE1 need to be
elucidated (12).
 |
CONCLUSIONS |
The KCNE1 knockout mouse displays a very complex
phenotype arising from direct effects due to the loss of the
KCNE1 protein and due to indirect compensatory mechanisms (Table
1). In most tissues KCNE1 probably
coassembles with KCNQ1; however, one has to be aware of other partner
proteins. In heart muscle the loss of KCNE1/KCNQ1 (6, 61)
and KCNE1/KCNH2 (4, 48) interaction, leaving homomeric
KCNQ1 and KCNH2 (HERG) channels behind (or these channels associated
with alternative partners), might explain the pronounced QT-RR
adaptability.
Like patients suffering from homozygous KCNE1 mutations (JLNS), the
mice are profoundly deaf. In addition, knockout mice suffer from severe
disturbance of the vestibular system, showing head bobbing and
bidirectional circling (Shaker-Waltzer behavior). In JLNS patients
other K+ channels and/or secondary mechanisms probably
largely compensate for vestibular defects.
Concerning the cardiac phenotype, the KCNE1 knockout mouse is an
interesting animal model for JLNS, offering the possibility of
extensive physiological and pharmacological experiments. Despite the
fact that there are evident limitations of this model, which are mostly
due to species differences in terms of heart rate, heart size, and
different levels of expression of ion channels, the KCNE1 knockout
mouse can help to obtain new insights in pathophysiology and
disease-related phenomena.
The data on renal ion and glucose transport suggest a functional
coupling of Na+ and glucose reabsorption to a luminal
KCNE1-dependent K+ conductance. Because many transport
mechanisms in small intestine are similar to those in renal proximal
tubules, the KCNE1 knockout mouse can be a useful tool to investigate
the possible role of KCNE1 for duodenal glucose and amino acid reabsorption.
The new observations on the role of KCNE1 for aldosterone secretion in
glomerulosa cells and plasma K+ homeostasis might be of
great importance for the treatment of JLNS patients because
life-threatening torsades de pointes arrhythmia often occurs during
hypokalemia. These patients could benefit from a slight increase in
plasma K+, i.e., via administration of spironolactone.
The present studies on the KCNE1 knockout mouse have provided new
knowledge on the pathophysiology of a gene whose human disease correlate was supposed to be well understood. These findings and future
studies will help to gain a more comprehensive understanding of KCNE1
physiology and perhaps a gene-specific treatment of patients.
 |
FOOTNOTES |
Address for reprint requests and other correspondence: R. Warth, Physiologisches Institut, Winterthurerstr. 190, 8057 Zürich, Switzerland (E-mail:
warthri{at}physiol.unizh.ch).
10.1152/ajpregu.00649.2001
 |
REFERENCES |
1.
Abbott, GW,
Butler MH,
Bendahhou S,
Dalakas MC,
Ptacek LJ,
and
Goldstein SA.
MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis.
Cell
104:
217-231,
2001[ISI][Medline].
2.
Abbott, GW,
Sesti F,
Splawski I,
Buck ME,
Lehmann MH,
Timothy KW,
Keating MT,
and
Goldstein SA.
MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia.
Cell
97:
175-187,
1999[ISI][Medline].
3.
Arrighi, I,
Bloch-Faure M,
Grahammer F,
Bleich M,
Warth R,
Mengual R,
Drici MD,
Barhanin J,
and
Meneton P.
Altered potassium balance and aldosterone secretion in a mouse model of human congenital long QT syndrome.
Proc Natl Acad Sci USA
98:
8792-8797,
2001[Abstract/Free Full Text].
4.
Attali, B,
Guillemare E,
Lesage F,
Honoré E,
Romey G,
Lazdunski M,
and
Barhanin J.
The protein IsK is a dual activator of K+ and Cl
channels.
Nature
365:
850-852,
1993[Medline].
5.
Attali, B,
Romey G,
Honore E,
Schmid-Alliana A,
Mattei MG,
Lesage F,
Ricard P,
Barhanin J,
and
Lazdunski M.
Cloning, functional expression, and regulation of two K+ channels in human T lymphocytes.
J Biol Chem
267:
8650-8657,
1992[Abstract/Free Full Text].
6.
Barhanin, J,
Lesage F,
Guillemare E,
Fink M,
Lazdunski M,
and
Romey G.
KvLQT1 and IsK (minK) proteins associate to form the IKs cardiac potassium current.
Nature
384:
78-80,
1996[Medline].
7.
Bianchi, L,
Priori SG,
Napolitano C,
Surewicz KA,
Dennis AT,
Memmi M,
Schwartz PJ,
and
Brown AM.
Mechanisms of IKs suppression in LQT1 mutants.
Am J Physiol Heart Circ Physiol
279:
H3003-H3011,
2000[Abstract/Free Full Text].
8.
Bleich, M,
and
Warth R.
The very small conductance K+ channel KvLQT1 and epithelial function.
Pflügers Arch
440:
202-206,
2000[ISI][Medline].
9.
Blumenthal, EM,
and
Kaczmarek LK.
The minK potassium channel exists in functional and nonfunctional forms when expressed in the plasma membrane of Xenopus oocytes.
J Neurosci
14:
3097-3105,
1994[Abstract].
10.
Busch, AE,
and
Suessbrich H.
Role of the IsK protein in the IminK channel complex.
Trends Pharmacol Sci
18:
26-29,
1997[Medline].
11.
Casimiro, MC,
Knollmann BC,
Ebert SN,
Vary JC,
Greene AE,
Franz MR,
Grinberg A,
Huang SP,
and
Pfeifer K.
Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen syndrome.
Proc Natl Acad Sci USA
98:
2526-2531,
2001[Abstract/Free Full Text].
12.
Chabannes, D,
Barhanin J,
and
Escande D.
Mice disrupted for the kvlqt1 potassium channel regulator isk gene accumulate mature t cells.
Cell Immunol
209:
1-9,
2001[ISI][Medline].
13.
Charpentier, F,
Merot J,
Riochet D,
Le Marec H,
and
Escande D.
Adult KCNE-1-knockout mice exhibit a mild cardiac cellular phenotype.
Biochem Biophys Res Commun
251:
806-810,
1998[ISI][Medline].
14.
Chen, XL,
Bayliss DA,
Fern RJ,
and
Barrett PQ.
A role for T-type Ca2+ channels in the synergistic control of aldosterone production by ANG II and K+.
Am J Physiol Renal Physiol
276:
F674-F683,
1999[Abstract/Free Full Text].
15.
Chevillard, C,
Attali B,
Lesage F,
Fontes M,
Barhanin J,
Lazdunski M,
and
Mattei MG.
Localization of a potassium channel gene (KCNE1) to 21q22.1-q222 by in situ hybridization and somatic cell hybridization.
Genomics
15:
243-245,
1993[ISI][Medline].
16.
Chouabe, C,
Neyroud N,
Guicheney P,
Lazdunski M,
Romey G,
and
Barhanin J.
Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias.
EMBO J
16:
5472-5479,
1997[ISI][Medline].
17.
Chouabe, C,
Neyroud N,
Richard P,
Denjoy I,
Hainque B,
Romey G,
Drici MD,
Guicheney P,
and
Barhanin J.
Novel mutations in KvLQT1 that affect IKs activation through interactions with IsK.
Cardiovasc Res
45:
971-980,
2000[Abstract/Free Full Text].
18.
Coetzee, WA,
Amarillo Y,
Chiu J,
Chow A,
Lau D,
McCormack T,
Moreno H,
Nadal MS,
Ozaita A,
Pountney D,
Saganich M,
d. Vega-Saenz M,
and
Rudy B.
Molecular diversity of K+ channels.
Ann NY Acad Sci
868:
233-285,
1999[ISI][Medline].
19.
Czirjak, G,
Fischer T,
Spat A,
Lesage F,
and
Enyedi P.
TASK (TWIK-related acid-sensitive K+ channel) is expressed in glomerulosa cells of rat adrenal cortex and inhibited by angiotensin II.
Mol Endocrinol
14:
863-874,
2000[Abstract/Free Full Text].
20.
Dedek, K,
and
Waldegger S.
Colocalization of KCNQ1/KCNE channel subunits in the mouse gastrointestinal tract.
Pflügers Arch
442:
896-902,
2001[ISI][Medline].
21.
Delpire, E,
Lu J,
England R,
Dull C,
and
Thorne T.
Deafness and imbalance associated with inactivation of the secretory Na-K-2Cl cotransporter.
Nat Genet
22:
192-195,
1999[ISI][Medline].
22.
Demolombe, S,
Franco D,
de Boer P,
Kuperschmidt S,
Roden D,
Pereon Y,
Jarry A,
Moorman AF,
and
Escande D.
Differential expression of KvLQT1 and its regulator IsK in mouse epithelia.
Am J Physiol Cell Physiol
280:
C359-C372,
2001[Abstract/Free Full Text].
23.
Deol, MS.
Inherited diseases of the inner ear in man in the light of studies on the mouse.
J Med Genet
5:
137-158,
1968[Free Full Text].
24.
Dixon, MJ,
Gazzard J,
Chaudhry SS,
Sampson N,
Schulte BA,
and
Steel KP.
Mutation of the Na-K-Cl cotransporter gene Slc12a2 results in deafness in mice.
Hum Mol Genet
8:
1579-1584,
1999[Abstract/Free Full Text].
25.
Drici, MD,
Arrighi I,
Chouabe C,
Mann JR,
Lazdunski M,
Romey G,
and
Barhanin J.
Involvement of IsK-associated K+ channel in heart rate control of repolarization in a murine engineered model of Jervell and Lange-Nielsen syndrome.
Circ Res
83:
95-102,
1998[Abstract/Free Full Text].
26.
Eckardt, L,
Haverkamp W,
Borggrefe M,
and
Breithardt G.
Experimental models of torsade de pointes.
Cardiovasc Res
39:
178-193,
1998[Abstract/Free Full Text].
27.
Felipe, A,
Knittle TJ,
Doyle KL,
Snyders DJ,
and
Tamkun MM.
Differential expression of IsK mRNAs in mouse tissue during development and pregnancy.
Am J Physiol Cell Physiol
267:
C700-C705,
1994[Abstract/Free Full Text].
28.
Flagella, M,
Clarke LL,
Miller ML,
Erway LC,
Giannella RA,
Andringa A,
Gawenis LR,
Kramer J,
Duffy JJ,
Doetschman T,
Lorenz JN,
Yamoah EN,
Cardell EL,
and
Shull GE.
Mice lacking the basolateral Na-K-2Cl cotransporter have impaired epithelial chloride secretion and are profoundly deaf.
J Biol Chem
274:
26946-26955,
1999[Abstract/Free Full Text].
29.
Folander, K,
Smith JS,
Antanavage J,
Bennett C,
Stein RB,
and
Swanson R.
Cloning and expression of the delayed-rectifier IsK channel from neonatal rat heart and diethylstilbestrol-primed rat uterus.
Proc Natl Acad Sci USA
87:
2975-2979,
1990[Abstract/Free Full Text].
30.
Friedmann, I,
Fraser GR,
and
Froggatt P.
Pathology of the ear in the cardioauditory syndrome of Jervell and Lange-Nielsen (recessive deafness with electrocardiographic abnormalities).
J Laryngol Otol
80:
451-470,
1966[Medline].
31.
Grahammer, F,
Herling AW,
Lang HJ,
Schmitt-Gräff A,
Wittekindt OH,
Nitschke R,
Bleich M,
Barhanin J,
and
Warth R.
The cardiac K+ channel KCNQ1 is essential for gastric acid secretion.
Gastroenterology
120:
1363-1371,
2001[ISI][Medline].
32.
Grahammer, F,
Warth R,
Barhanin J,
Bleich M,
and
Hug MJ.
The small conductance K+ channel, KCNQ1. Expression, function, and subunit composition in murine trachea.
J Biol Chem
246:
42268-42275,
2001.
33.
Hirao, H,
Shimizu W,
Kurita T,
Suyama K,
Aihara N,
Kamakura S,
and
Shimomura K.
Frequency-dependent electrophysiologic properties of ventricular repolarization in patients with congenital long QT syndrome.
J Am Coll Cardiol
28:
1269-1277,
1996[Abstract].
34.
Hoppe, UC,
Marban E,
and
Johns DC.
Distinct gene-specific mechanisms of arrhythmia revealed by cardiac gene transfer of two long QT disease genes, HERG and KCNE1.
Proc Natl Acad Sci USA
98:
5335-5340,
2001[Abstract/Free Full Text].
35.
Hwang, T,
Suh D,
Bae H,
Lee S,
and
Jung J.
Characterization of K+ channels in the basolateral membrane of rat tracheal epithelia.
J Membr Biol
154:
251-257,
1996[ISI][Medline].
36.
Karet, FE,
Finberg KE,
Nelson RD,
Nayir A,
Mocan H,
Sanjad SA,
Rodriguez-Soriano J,
Santos F,
Cremers CW,
Di Pietro A,
Hoffbrand BI,
Winiarski J,
Bakkaloglu A,
Ozen S,
Dusunsel R,
Goodyer P,
Hulton SA,
Wu DK,
Skvorak AB,
Morton CC,
Cunningham MJ,
Jha V,
and
Lifton RP.
Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness.
Nat Genet
21:
84-90,
1999[ISI][Medline].
37.
Kawai, J,
Shinagawa A,
Shibata K,
Yoshino M,
Itoh M,
Ishii Y,
Arakawa T,
Hara A,
Fukunishi Y,
Konno H,
Adachi J,
Fukuda S,
Aizawa K,
Izawa M,
Nishi K,
Kiyosawa H,
Kondo S,
Yamanaka I,
Saito T,
Okazaki Y,
Gojobori T,
Bono H,
Kasukawa T,
Saito R,
Kadota K,
Matsuda HA,
Ashburner M,
Batalov S,
Casavant T,
Fleischmann W,
Gaasterland T,
Gissi C,
King B,
Kochiwa H,
Kuehl P,
Lewis S,
Matsuo Y,
Nikaido I,
Pesole G,
Quackenbush J,
Schriml LM,
Staubli F,
Suzuki R,
Tomita M,
Wagner L,
Washio T,
Sakai K,
Okido T,
Furuno M,
Aono H,
Baldarelli R,
Barsh G,
Blake J,
Boffelli D,
Bojunga N,
Carninci P,
de Bonaldo MF,
Brownstein MJ,
Bult C,
Fletcher C,
Fujita M,
Gariboldi M,
Gustincich S,
Hill D,
Hofmann M,
Hume DA,
Kamiya M,
Lee NH,
Lyons P,
Marchionni L,
Mashima J,
Mazzarelli J,
Mombaerts P,
Nordone P,
Ring B,
Ringwald M,
Rodriguez I,
Sakamoto N,
Sasaki H,
Sato K,
Schonbach C,
Seya T,
Shibata Y,
Storch KF,
Suzuki H,
Toyo-oka K,
Wang KH,
Weitz C,
Whittaker C,
Wilming L,
Wynshaw-Boris A,
Yoshida K,
Hasegawa Y,
Kawaji H,
Kohtsuki S,
and
Hayashizaki Y.
Functional annotation of a full-length mouse cDNA collection.
Nature
409:
685-690,
2001[Medline].
38.
Keating, MT,
and
Sanguinetti MC.
Molecular and cellular mechanisms of cardiac arrhythmias.
Cell
104:
569-580,
2001[ISI][Medline].
39.
Kim, SJ,
and
Greger R.
Voltage-dependent, slowly activating K+ current (IKs) and its augmentation by carbachol in rat pancreatic acini.
Pflügers Arch
438:
604-611,
1999[ISI][Medline].
40.
Kupershmidt, S,
Yang T,
Anderson ME,
Wessels A,
Niswender KD,
Magnuson MA,
and
Roden DM.
Replacement by homologous recombination of the minK gene with lacZ reveals restriction of minK expression to the mouse cardiac conduction system.
Circ Res
84:
146-152,
1999[Abstract/Free Full Text].
41.
Lee, MP,
Ravenel JD,
Hu RJ,
Lustig LR,
Tomaselli G,
Berger RD,
Brandenburg SA,
Litzi TJ,
Bunton TE,
Limb C,
Francis H,
Gorelikow M,
Gu H,
Washington K,
Argani P,
Goldenring JR,
Coffey RJ,
and
Feinberg AP.
Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice.
J Clin Invest
106:
1447-1455,
2000[ISI][Medline].
42.
Lesage, F,
Attali B,
Lakey J,
Honore E,
Romey G,
Faurobert E,
Lazdunski M,
and
Barhanin J.
Are Xenopus oocytes unique in displaying functional IsK channel heterologous expression?
Receptors Channels
1:
143-152,
1993[ISI][Medline].
43.
Letts, VA,
Valenzuela A,
Dunbar C,
Zheng QY,
Johnson KR,
and
Frankel WN.
A new spontaneous mouse mutation in the kcne1 gene.
Mamm Genome
11:
831-835,
2000[ISI][Medline].
44.
Lock, H,
and
Valverde MA.
Contribution of the IsK (MinK) potassium channel subunit to regulatory volume decrease in murine tracheal epithelial cells.
J Biol Chem
275:
34849-34852,
2000[Abstract/Free Full Text].
45.
Lotshaw, DP.
Characterization of angiotensin II-regulated K+ conductance in rat adrenal glomerulosa cells.
J Membr Biol
156:
261-277,
1997[ISI][Medline].
46.
Marcus, DC,
and
Shen Z.
Slowly activating voltage-dependent K+ conductance is apical pathway for K+ secretion in vestibular dark cells.
Am J Physiol Cell Physiol
267:
C857-C864,
1994[Abstract/Free Full Text].
47.
Marcus, DC,
Sunose H,
Liu J,
Shen Z,
and
Scofield MA.
P2u purinergic receptor inhibits apical IsK/KvLQT1 channel via protein kinase C in vestibular dark cells.
Am J Physiol Cell Physiol
273:
C2022-C2029,
1997[Abstract/Free Full Text].
48.
McDonald, TV,
Yu ZH,
Ming Z,
Palma E,
Meyers MB,
Wang KW,
Goldstein SA,
and
Fishman GI.
A minK-HERG complex regulates the cardiac potassium current I-Kr.
Nature
388:
289-292,
1997[Medline].
49.
Meissner FL. Taubstummheit und Taubstummenbildung.
Heidelberg, Germany, 1856.
50.
Neyroud, N,
Maison-Blanche P,
Denjoy I,
Chevret S,
Donger C,
Dausse E,
Fayn J,
Badilini F,
Menhabi N,
Schwartz K,
Guicheney P,
and
Coumel P.
Diagnostic performance of QT interval variables from 24-h electrocardiography in the long QT syndrome.
Eur Heart J
19:
158-165,
1998[Abstract/Free Full Text].
51.
Neyroud, N,
Tesson F,
Denjoy I,
Leibovici M,
Donger C,
Barhanin J,
Faure S,
Gary F,
Coumel P,
Petit C,
Schwartz K,
and
Guicheney P.
A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome.
Nat Genet
15:
186-189,
1997[ISI][Medline].
52.
Nicolas, M,
Dememes D,
Martin A,
Kupershmidt S,
and
Barhanin J.
KCNQ1/KCNE1 potassium channels in mammalian vestibular dark cells.
Hear Res
153:
132-145,
2001[ISI][Medline].
53.
Pereon, Y,
Demolombe S,
Baro I,
Drouin E,
Charpentier F,
and
Escande D.
Differential expression of KvLQT1 isoforms across the human ventricular wall.
Am J Physiol Heart Circ Physiol
278:
H1908-H1915,
2000[Abstract/Free Full Text].
54.
Pitt, B,
Zannad F,
Remme WJ,
Cody R,
Castaigne A,
Perez A,
Palensky J,
and
Wittes J.
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
N Engl J Med
341:
709-717,
1999[Abstract/Free Full Text].
55.
Priori, SG,
Barhanin J,
Hauer RN,
Haverkamp W,
Jongsma HJ,
Kleber AG,
McKenna WJ,
Roden DM,
Rudy Y,
Schwartz K,
Schwartz PJ,
Towbin JA,
and
Wilde A.
Genetic and molecular basis of cardiac arrhythmias; impact on clinical management. Study group on molecular basis of arrhythmias of the working group on arrhythmias of the European Society of Cardiology.
Eur Heart J
20:
174-195,
1999[Free Full Text].
56.
Priori, SG,
Napolitano C,
Tiso N,
Memmi M,
Vignati G,
Bloise R,
Sorrentino V,
and
Danieli GA.
Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.
Circulation
103:
196-200,
2001[Abstract/Free Full Text].
57.
Roberts, R,
and
Brugada R.
Genetic aspects of arrhythmias.
Am J Med Genet
97:
310-318,
2000[ISI][Medline].
58.
Roden, DM.
A practical approach to torsade de pointes.
Clin Cardiol
20:
285-290,
1997[ISI][Medline].
59.
Sakagami, M,
Fukazawa K,
Matsunaga T,
Fujita H,
Mori N,
Takumi T,
Ohkubo H,
and
Nakanishi S.
Cellular localization of rat Isk protein in the stria vascularis by immunohistochemical observation.
Hear Res
56:
168-172,
1991[ISI][Medline].
60.
Sanguinetti, MC.
Maximal function of minimal K+ channel subunits.
Trends Pharmacol Sci
21:
199-201,
2000[Medline].
61.
Sanguinetti, MC,
Curran ME,
Zou A,
Shen J,
Spector PS,
Atkinson DL,
and
Keating MT.
Coassembly of KvLQT1 and minK (IsK) proteins to form cardiac IKs potassium channel.
Nature
384:
80-83,
1996[Medline].
62.
Schott, JJ,
Charpentier F,
Peltier S,
Foley P,
Drouin E,
Bouhour JB,
Donnelly P,
Vergnaud G,
Bachner L,
and
Moisan JP.
Mapping of a gene for long QT syndrome to chromosome 4q25-27.
Am J Hum Genet
57:
1114-1122,
1995[ISI][Medline].
63.
Schroeder, BC,
Waldegger S,
Fehr S,
Bleich M,
Warth R,
Greger R,
and
Jentsch TJ.
A constitutively open potassium channel formed by KCNQ1 and KCNE3.
Nature
403:
196-199,
2000[Medline].
64.
Shen, Z,
and
Marcus DC.
Divalent cations inhibit IsK/KvLQT1 channels in excised membrane patches of strial marginal cells.
Hear Res
123:
157-167,
1998[ISI][Medline].
65.
Suessbrich, H,
and
Busch AE.
The IKs channel: coassembly of IsK (minK) and KvLQT1 proteins.
Rev Physiol Biochem Pharmacol
137:
191-226,
1999[Medline].
66.
Sugimoto, T,
Tanabe Y,
Shigemoto R,
Iwai M,
Takumi T,
Ohkubo H,
and
Nakanishi S.
Immunohistochemical study of a rat membrane protein which induces a selective potassium permeation: its localization in the apical membrane portion of epithelial cells.
J Membr Biol
113:
39-47,
1990[ISI][Medline].
67.
Sunose, H,
Liu J,
and
Marcus DC.
cAMP increases K+ secretion via activation of apical IsK/KvLQT1 channels in strial marginal cells.
Hear Res
114:
107-116,
1997[ISI]